tiprankstipranks
Trending News
More News >
Pharmarise Holdings Corp. (JP:2796)
:2796
Japanese Market
Advertisement

Pharmarise Holdings Corp. (2796) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Pharmarise Holdings Corp. has a market cap or net worth of ¥6.15B. The enterprise value is ¥16.65B.
Market Cap¥6.15B
Enterprise Value¥16.65B

Share Statistics

Pharmarise Holdings Corp. has 12,060,381 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,060,381
Owned by Insiders
Owned by Institutions

Financial Efficiency

Pharmarise Holdings Corp.’s return on equity (ROE) is -0.05 and return on invested capital (ROIC) is -61.72%.
Return on Equity (ROE)-0.05
Return on Assets (ROA)-0.01
Return on Invested Capital (ROIC)-61.72%
Return on Capital Employed (ROCE)0.01
Revenue Per Employee34.37M
Profits Per Employee4.33K
Employee Count1,848
Asset Turnover1.99
Inventory Turnover13.16

Valuation Ratios

The current PE Ratio of Pharmarise Holdings Corp. is ―. Pharmarise Holdings Corp.’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value0.80
Price to FCF
Price to Operating Cash Flow13.44
PEG Ratio

Income Statement

In the last 12 months, Pharmarise Holdings Corp. had revenue of 63.51B and earned -367.00M in profits. Earnings per share was -32.42.
Revenue63.51B
Gross Profit8.96B
Operating Income293.00M
Pretax Income8.00M
Net Income-367.00M
EBITDA1.68B
Earnings Per Share (EPS)-32.42

Cash Flow

In the last 12 months, operating cash flow was 427.00M and capital expenditures -77.50M, giving a free cash flow of 349.50M billion.
Operating Cash Flow427.00M
Free Cash Flow349.50M
Free Cash Flow per Share28.98

Dividends & Yields

Pharmarise Holdings Corp. pays an annual dividend of ¥14, resulting in a dividend yield of 2.69%
Dividend Per Share¥14
Dividend Yield2.69%
Payout Ratio-165.68%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.29
52-Week Price Change-15.35%
50-Day Moving Average506.98
200-Day Moving Average492.57
Relative Strength Index (RSI)52.95
Average Volume (3m)15.14K

Important Dates

Pharmarise Holdings Corp. upcoming earnings date is Dec 17, 2025, TBA (Confirmed).
Last Earnings DateSep 25, 2025
Next Earnings DateDec 17, 2025
Ex-Dividend DateMay 29, 2025

Financial Position

Pharmarise Holdings Corp. as a current ratio of 1.10, with Debt / Equity ratio of 207.94%
Current Ratio1.10
Quick Ratio0.76
Debt to Market Cap2.49
Net Debt to EBITDA5.58
Interest Coverage Ratio1.65

Taxes

In the past 12 months, Pharmarise Holdings Corp. has paid 391.00M in taxes.
Income Tax391.00M
Effective Tax Rate48.88

Enterprise Valuation

Pharmarise Holdings Corp. EV to EBITDA ratio is 8.85, with an EV/FCF ratio of 24.40.
EV to Sales0.23
EV to EBITDA8.85
EV to Free Cash Flow24.40
EV to Operating Cash Flow11.33

Balance Sheet

Pharmarise Holdings Corp. has ¥2.24B in cash and marketable securities with ¥14.25B in debt, giving a net cash position of -¥12.00B billion.
Cash & Marketable Securities¥2.24B
Total Debt¥14.25B
Net Cash-¥12.00B
Net Cash Per Share-¥995.33
Tangible Book Value Per Share-¥30.91

Margins

Gross margin is 13.49%, with operating margin of 0.46%, and net profit margin of -0.58%.
Gross Margin13.49%
Operating Margin0.46%
Pretax Margin0.01%
Net Profit Margin-0.58%
EBITDA Margin2.64%
EBIT Margin0.29%

Analyst Forecast

The average price target for Pharmarise Holdings Corp. is ¥520.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target¥520.00
Price Target Upside0.00%
Analyst ConsensusHold
Analyst Count0
Revenue Growth Forecast15.66%
EPS Growth Forecast56.93%

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis